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Introduction 
Diabetes is the seventh leading cause of death in Australia (1), contributing significantly to 
premature mortality, morbidity, disability and potential years of life lost (2).  From the 1995 
National Health Survey (NHS), it was estimated that 430,700 individuals (2.4 per cent of the total 
population) reported having been diagnosed with diabetes at some stage in their life, and that a 
further 300,000 (1.5 per cent of the population) have undiagnosed diabetes (1).  In 1996, the 
Australian Health Ministers declared diabetes as the fifth National Health Priority Area (NHPA), as 
several of the criteria for priority national attention were met (2).  These included: 
• high overall burden of the disease in terms of mortality, morbidity and disability; 
• potential for health gain through prevention of the disease or lessening its impact 
• existence of cost-effective interventions; and 
• disproportionate impact upon certain segments of the population. 
There are three main types of diabetes:  
• Type 1 diabetes – Insulin dependent diabetes, occurs when the pancreas gland no longer 
produces enough insulin to convert glucose into energy.  This type represents 
approximately 15 per cent of all cases of diabetes.   
• Type 2 diabetes – represents approximately 85 per cent of all cases of diabetes and is 
known to be promoted by lifestyle factors such as lack of exercise, and unhealthy diet 
contributing to obesity.  Occurs when the pancreas is not producing effective insulin. 
• Gestational diabetes – it occurs in at least six per cent of pregnancies, increasing the risk 
of pregnancy complications (6).   
Diabetes is the most common cause of end-stage renal disease, of new onset blindness in the 
working age population, and of lower limb amputations, and a noted risk factor for cardiovascular 
disease (10).  Diabetes and its complications (cardiovascular, kidney and eye diseases) were 
estimated to contribute to 2.2 per cent (approximately $681 million per annum) of the total health 
system costs in the period from 1993-1994 (2).   
This discussion paper examines a number of issues related to diabetes and the instruments 
that have been used to measure diabetes in the population.  In particular, the paper looks at health 
surveillance data collection. 
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What Should Be Measured? 
The measurement of diabetes and the detail included in any data collection clearly relate to the 
purpose of the collection.  A number of issues are related to this, including: 
• Should we be including all six National Health Priority Areas Indicators for diabetes? 
• Should coverage of the population be restricted to adults only (over 18 years) or expanded to 
cover young people, adolescents and children? 
• Is diabetes worth measuring without conjoint information on physical activity or obesity? 
• Can point-in-time measurement be enhanced to give incidence, providing some data towards 
pictures of peoples’ lifetime management of diabetes? 
• What kind of comparability is required of the measuring instruments (intra-population, 
international, cross-cultural, over time)? 
Purpose of Measuring Diabetes 
A number of questions related to diabetes measurement need to be answered. 
• What is the purpose of measuring diabetes in a population survey? 
• What is it we want to measure? 
• With what do we want to compare the answers? 
The answers to these questions include the following: 
• To assess population risk factor prevalence over time. 
• To provide evidence for outcomes-based research into diabetes. 
• Using internationally agreed questionnaires and other instruments and measures to provide 
international comparability. 
• To document the effect of health promotion activities (and other items such as changes in the 
built environment) directed at changing population behaviours. 
• To improve population benchmarking. 
• For longitudinal tracking as the population moves through different age cohorts. 
• To keep the issues in the public eye. 
• To allow targeting of sub-populations. 
• To assist in tailoring intervention materials or programs aimed at behavioural change. 
• To monitor specific population-wide goals. 
• To provide information to professionals (eg, General Practitioners) on health promotions and/or 
interventions that work. 
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• For monitoring the relationship with other key risk factors (such as overweight, physical 
inactivity). 
• To identify areas to invest in (eg, physical activity). 
• To better predict populations at high risk. 
• To examine environmental factors that may enhance or impede peoples’ ability or desire to 
engage in (more) physical activity or maintain a good nutritional status. 
Population Surveillance Concepts 
Public health surveillance of diabetes and its complications is critical for increasing the recognition 
of the disease, identifying high-risk groups, developing strategies to reduce the economic and 
human cost of this disease, formulating health care policy, and evaluating progress in disease 
prevention and control (4).   
Analyses and assessments of health are moving into whole-of-population models and 
including information on non-medical factors (ethnicity, gender) and ‘health related behaviour’ 
(20).  The population risk factor surveillance model implies that personal behaviours can influence 
peoples’ health status.  A number of lifestyle risk factors are known to increase the risk of 
developing diabetes, including obesity and physical inactivity.  The risk of developing Type 2 
diabetes is approximately five to ten times greater in obese individuals than in those with an 
acceptable weight, and the risk of developing diabetes is 30 to 60 per cent lower among regular 
exercisers (2).  Additional modifiable risk factors include income inadequacy, smoking and 
hypertension (10).  There is strong evidence that diabetes could be prevented by reducing or 
preventing cardiovascular risk factors (4).  This can be achieved through the promotion of physical 
activity, weight control, smoking prevention and cessation, hypertension prevention and blood 
pressure control, and lipid and glycemic control.  
Scope 
As with any self-reported data there are limitations.  Survey data based on self-reported diabetes are 
limited as about half of persons with diabetes do not know they have the disease (9).  This can have 
major implications when planning diabetes services.  Survey data do not detect people with 
undiagnosed diabetes unless a blood sample is taken (10). 
A study, undertaken in Finland, assessed the agreement and validity of a self-administered 
questionnaire on selected chronic diseases with information documented in medical records.  The 
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results showed there to be substantial agreement on the occurrence of diabetes.  However, the 
prevalence of diabetes based on questionnaire responses was lower than that recorded in medical 
records when based on both definite and possible diagnosis and higher when based on definite 
diagnosis alone.  This high level of agreement was shown for a number of chronic 
conditions/diseases that have clear diagnostic criteria and are easily communicated to patients (22).   
For a large proportion of individuals that had been diagnosed with Type 1 diabetes, 
answering questions concerning their disease are often straightforward.  Type 1 diabetes affects the 
life of the individual considerably, unlike Type 2 diabetic patients who often have less pronounced 
symptoms, have an easier treatment and their mean age is greater (16).  For these individuals the 
risk of misunderstanding or answering questions concerning diabetes incorrectly is increased.  A 
number of diabetic patients who’s condition is managed by diet often believe that they no longer 
have the disease, thus in order to avoid this misunderstanding the question that is often used is ‘Do 
you have or have you had diabetes?”   
A number of frequently asked questions in national health surveys are interpreted differently 
across cultural groups (5) and even among cultures.  A study undertaken by Johnston et al. looked 
at label preferences for the disease diabetes mellitus across cultures.  The study revealed, that 
overall 88.3 per cent of Americans preferred the term “diabetes” and the remaining 11.7 per cent 
selected other labels, including “sugar diabetes”, “sugar”, or “high sugar”.  Table 1 shows that 
African Americans were more likely to prefer labels other than “diabetes” than non-Hispanic 
whites.  A similar analysis was conducted for the term “hypertension”.  From this analyses the label 
“high blood pressure” was endorsed 78.8 per cent of the time, while the term “hypertension” was 
preferred 17.3 per cent of the time (11.3 per cent for Mexican Americans compared with 18.8 per 
cent for non-Hispanic whites).   
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Table 1.  Responses to disease label probes by cultural group (percentages) 
Probes 
[a] “Next I’d like to ask you about a disease that is referred to by many names.  Please look at this 
card and tell me which name you would call it.  [diabetes, sugar diabetes, sugar, high sugar, 
something else (specify)].” 
[b] “Now please look at this card and tell me which name you would actually call this problem.  













[a] Selected “diabetes” 81.7 90.3 87.6 93.6 
[b] Selected “hypertension” 25.7 11.3 13.1 18.8 
Source: Centres for Disease Control and Prevention, 1996 
In South Australia, there is evidence to suggest that diabetes has been underreported in 
surveys such as the SERCIS and Health Omnibus Surveys due to label preferences (14).  Rather 
than diabetes, some people believe they have ‘a touch of sugar’ or ‘high blood sugar’.  As a 
consequence of label preferences, an additional question on diabetes was included in the 1998 
Health Priority Areas Survey.  This question asked respondents who did not answer yes to having 
been told they have diabetes as to whether they had been told by a doctor that they had ‘high blood 
sugar’ or ‘a touch of sugar’.  It was estimated that the ‘high blood sugar’ prevalence rates for males 
and females (outside of pregnancy) was 1.7 per cent, indicating that there may be nearly 50 per cent 
more cases of diabetes in South Australia than previously estimated.   
A study undertaken in Pu-Li to compare the prevalence of diabetes in two surveys, 
suggested that in areas where health awareness and the widespread use of traditional medicine is an 
issue, it is better to include treatment history of diabetes rather than depending on self-reporting 
alone (23).   
Population Coverage 
Most population-based instruments have focussed on adult populations per se, despite the fact that 
diabetes Type 1 is one of the most common chronic conditions of childhood.  Diabetes Type 1 
(juvenile diabetes) is likely to have a higher incidence in children under 20 years of age than cancer, 
cystic fibrosis, multiple sclerosis, juvenile rheumatoid arthritis and muscular dystrophy (19).   
The 1995 Australian National Health Survey, however, interviewed persons aged 18 years 
or over personally, those aged 15-17 years with the consent of a parent or guardian, and obtained 
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information for persons aged less than 15 years from a person responsible for the child (3).  
Nationally, diabetes has been measured in the Australian Bureau of Statistics (ABS) National 
Health Survey (Attachment A), and at a State level it has been measured in South Australia, 
Queensland, Victoria, Western Australia and New South Wales.   
Relationship to Other Factors 
Evidence is increasing that in some populations, non-insulin dependent diabetes shares common 
causal factors with cardiovascular disease and in particular with coronary heart disease (15).  In a 
number of studies from selected populations, an inverse relationship between physical activity level 
and the risk of subsequent non-insulin dependent diabetes (reported by patients to have been 
diagnosed by a doctor), has been described  (12, 17, 18).  It is also well documented that physical 
inactivity is a risk factor for cardiovascular disease (21).  Likewise, obesity is a well-known risk 
factor for both diabetes and coronary heart disease.  These findings emphasize the interrelations 
between risk factors for non-insulin dependent diabetes and coronary heart disease and the potential 
value of an integrated approach to the prevention of these conditions based on the prevention of 
obesity and the promotion of physical activity (13).   
Diabetes Indicators 
The National Health Information Management Group (NHIMG) Working Party on Health 
Outcomes Activities and Priorities developed a set of priority indicators for monitoring and 
reporting diabetes.  These indicators (shown in Table 2) are likely to be influential, valid and 
reliable measures for monitoring progress towards better health outcomes in Australia (2).   
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Table 2: NHPA Indicators 
Indicator  1998 reporting 
1 Disease incidence and prevalence 
1.1 Prevalence rates for Type 1 and Type 2 diabetes in:  9 
a) general population: 
b) indigenous population; and 
c) among people from culturally and linguistically diverse background. 
1.2 Incidence rates for Type 1 and Type 2 diabetes in:  ✗  
a) general population: 
b) indigenous population; and 
c) among people from culturally and linguistically diverse background. 
1.3 Gestational diabetes among women aged 20-44 years ✗  
2 Risk factors for diabetes and associated complications 
2.1 Prevalence rates for obesity and being overweight (as measured by BMI) in: 9 
a) general population; and 
b) among persons with Type 2 diabetes 
2.2 Rates for non-participation in regular sustained, moderate aerobic exercise in: 9 
a) general population; and 
b) among persons with Type 2 diabetes 
2.3 Prevalence rates for high blood pressure among persons with Type 2 diabetes: 9 
a) ≥ 140 mmHg systolic and/or 90 mmHg diastolic and aged <60 years; 
b) ≥ 160 mmHg systolic and/or 90 mmHg diastolic and aged ≥60 years; and/or 
c) those on medication for high blood pressure 
2.4 Prevalence rates for high levels of lipoproteins among persons with Type 1 and  
Type 2 diabetes: 9 
a) total cholesterol above 5.5 mmol/L; and 
b) high density lipoproteins below 1.0 mmol/L 
2.5 Prevalence rates for fasting hypertriglyceridaemia among persons with Type 1 and  
Type 2 diabetes 9 
3 Diabetes complications 
3.1 Proportion of persons with end-stage renal disease with diabetic nephropathy as a  
casual factor 9 
3.2 Incidence rate for eye disease among clinically diagnosed persons with diabetes 9 
3.3 Prevalence rate for foot problems among clinically diagnosed persons with diabetes 9 
3.4 Incidence rates for coronary heart disease and stroke in: 9 
a) general population; and 
b) among clinically diagnosed persons with diabetes 
4 Hospital separations for diabetes complications 
4.1 Hospital separation rate for end-stage renal disease where diabetes is an additional  
Diagnosis 9 
4.2 Hospital separation rate for coronary heart disease or stoke where diabetes is an  
additional diagnosis 9 
4.3 Hospital separation rate for conditions other than end-stage renal disease and coronary  
heart disease/stroke among: 9 
a) persons with diabetes as primary diagnosis or an additional diagnosis; and 
b) persons without diabetes as a reported diagnosis 
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Indicator  1998 reporting 
5 Mortality 
5.1 Death rates for diabetes in: 9 
a) general population; 
b) indigenous population; and 
c) among people from culturally and linguistically diverse backgrounds 
5.2 Death rates for coronary heart disease and stroke among persons with diabetes in; ✗  
a) general population; 
b) indigenous population; and 
c) among people from culturally and linguistically diverse backgrounds 
6 Health Status 
6.1 Self-assessed health status of persons with and without diabetes 9 
7 Screening and management 
7.1 Proportion of persons with diabetes tested for glycosylated haemoglobin level  
at least every six months ✗  
7.2 Proportion of pregnant women being tested for gestational diabetes ✗  
Source: Australian Institute of Health and Welfare, 1998 
Indicators Suitable for CATI Surveys 
1 Disease incidence and prevalence 
Indicators 1.1, 1.2 and 1.3 are suitable for CATI surveys.   
Self-reported prevalence rates of diabetes in the general population and among those from 
culturally and linguistic diverse backgrounds was collected by the ABS in the 1995 NHS.  In the 
1994 NATSIS, self-reported prevalence rates were collected for Indigenous Australians (2).  This 
information has also been collected from a number of State-based surveys. 
Incidence rates have been collected in South Australia from the Health Goals & Targets 
Health Priorities Area Survey in 1998.   
In a number of surveys, to determine the prevalence of gestational diabetes, women are 
asked whether or not they were pregnant when they were first diagnosed with diabetes.   
   9
2 Risk factors for diabetes and associated complications 
Indicators 2.1 and 2.2 are suitable for CATI surveys.   
The NHS, along with a number of other surveys, collects self-reported height and weight 
measurements.  An individual with a Body Mass Index (BMI, expressed as weight/height squared) 
of 30 kg/m2 or more is considered obese. 
Questions regarding regular, sustained and moderate aerobic exercise are frequently asked in 
health related surveys.  These questions usually indicate participation levels in physical activity for 
recreation or fitness purposes over a two-week period. 
There are currently no population-based, national estimates of prevalence of high blood 
pressure among persons with diabetes, based on actual measurements (2).  Neither can this 
information be collected in a CATI based survey, therefore measurements on high blood pressure 
must rely on self-reports.   
3 Diabetes complications 
Indicators 3.2 and 3.3 are suitable for CATI surveys.   
Eye diseases or conditions that are related to diabetes include vision-threatening retinopathy, 
cataracts, glaucoma and blindness (2).  Currently this information is only being collected by the 
National Association of Diabetes Centres (NADC) Survey.  The NADC survey includes diabetic 
patients requiring specialist clinical management, therefore it may not give a true picture of eye 
diseases/conditions in the general community.   
Foot problems, including ulcers, gangrene and loss of sensitivity to pain and trauma, along 
with lower leg amputation are used as the two end-points for monitoring persons with clinically 
diagnosed diabetes.  This information has been collected in the 1995 NHS for lower leg amputation 
and estimates of foot ulcers are based on the NADC data.   
6 Health Status 
Indicator 6.1 is suitable for a CATI survey 
Respondents of the 1995 NHS and SF-36 were asked how they would say there health is: 
Excellent, very good, good, fair or poor?  This indicator therefore compares people with and 
without diabetes in the general population as to whether they rate their health as ‘good, very good or 
excellent’ or ‘fair or poor’.   
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International Surveys 
The following table outlines a number of international surveys that have included questions on diabetes.   
Table 3: International Surveys 
United States 







Definition of diabetes 
National Health Interview Survey 1998 107,000 non-institutionalized 
United States residents 
All Have you EVER been told by a doctor or 
health professional that you have diabetes 
or sugar diabetes? 
Behavioral Risk Factor Surveillance 
System 
Ongoing 200/month non-institutionalized 
United States residents 
18+ Have you ever been told by a doctor that 
you have diabetes? 
National Health and Nutrition 
Examination Survey 
Ongoing 5,000 annually 15 U.S. locations a year  {Other than during pregnancy, {have 
you/has SP}/{Have you/Has SP}} ever 
been told by a doctor or health 
professional that {you have/{he/she/SP} 
has} diabetes or sugar diabetes? 
Wisconsin Family Health Survey 1998 2,463 hh 
annually/ 6,560 
persons 
stratified random sample 
of households in 
Wisconsin 
All ……please tell me whether you or 
anyone in your household has ever been 
told by a doctor that they 
have……Diabetes? 
Canada 
General Social Survey 1985 11,200 
(19,669,000) 
10 provinces 15+ Do you have diabetes? 
General Social Survey 1991 11,924 
(20,980,862) 
10 provinces 15+ Do you have diabetes? 
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Definition of diabetes 
National Longitudinal Survey of 
Children and Youth 
1994/95 22,831 
(4,673,390) 
Provinces and territories; 
diabetes question asked of 
only women with children 




During pregnancy, did you suffer from 
pregnancy diabetes? 




10 provinces; all long-
term residents of selected 
health care institutions 
12+ Do you have diabetes that has been 
diagnosed by a health care professional? 




10 provinces; no Indian 
reserves 
12+ Do you have diabetes that has been 
diagnosed by a health care professional? 
Hawaii 
Hawaii Health Survey 1996 12,923 Statewide households 
(4,382), the respondent 
was the person who was 
most knowledgeable about 
their household 
18+ Has anyone in the household been told by 
a physician or medical professional that 
they have diabetes? 
Norway 
The Nord-Trondelag health survey 1984-86 76,885 
 
all inhabitants 20+ Do you have any of the following 
diseases…..Diabetes? 
England 





living in private 
households in England.   
2+ Do you now have or have you ever had 
Diabetes? 
National Survey of Physical Activity 
and Health 
1991 4200 112 parliamentary 
constituencies 
adults Have you ever had any of the 
following….Diabetes? 
Wales 
The Welsh Health Survey 1995 50,000 Electoral role adults Do you have Diabetes/ 
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In addition to the core questions asked in the Behavioural Risk Factor Surveillance System 
(BRFSS), an optional module (see Attachment B) on diabetes can be asked at each states 
discretion.  The National Health and Nutrition Examination Survey (NHANES) (see Attachment 
C) also ask additional questions on diabetes that covers most of the indicators that are suitable in 
CATI surveys.   
International Surveillance 
The Centres for Disease Control and Prevention (CDC) has established an ongoing surveillance 
system that collects, analyses and disseminates national data on diabetes and its complications.  
The data, although representative, tends to be insufficient for analysing national trends among 
minority groups (4).  This is of particular concern, as many studies show that minority populations 
are disproportionably affected by diabetes (7, 8, 10, 24, 26).   
Since 1996, the National Diabetes Surveillance System (NDSS) has been committed to 
improving surveillance of diabetes at the national, provincial/territorial, and community levels 
(including Aboriginal people) to monitor the human and economic burden of diabetes in the 
Canadian population.  The data will be used to provide accurate baseline data on the prevalence 
and incidence of diabetes and its complications, identify high risk groups/areas and to identify 
change, to assist health professionals in the planning of diabetes prevention and control programs.  
Through the partnerships with Aboriginal groups and government, the NDSS has the potential to 
provide diabetes information concerning Aboriginal Peoples living off-reserve or using health 
services off-reserve, and to be coordinated or integrated with other Aboriginal data information 
systems (11).   
Current Data Limitations 
• about half the people with diabetes are not aware that they have the disease 
• most samples do not include persons in institutional settings, however it is these people that 
are more likely to have diabetes 
• information collected is not verified 
• respondents may not remember essential information 
• the same question may not mean the same thing to different respondents 
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• proxy respondents are likely to underreport diabetes 
• the sample does not include any households without telephones 
• prevalence data is based on self-report, which may lead to over or under reporting 
• there is no standardisation of diabetes data collected from different sources in Australia (2) 
Improving Data Development and Information Systems 
The NHPA Report outlines several ways in which national data concerning diabetes could be 
improved in order to assist in the development of health planning and resource allocation.  These 
include: 
• Development of standard definitions for each aspect of monitoring would enable consistent 
information to be collected by the various diabetes health service providers, and outcomes 
to be evaluated in relation to health service utilisation. 
• Inclusion of agreed diabetes fields into existing national minimum datasets is essential to 
obtain timely and accurate data. 
• Surveys and other data collection instruments are required to determine and monitor the 
incidence and prevalence of diabetes in the general population and in special population 
groups. 
• A mechanism that promotes data linkage across service settings has the potential to 
increase efficiency and improve diabetes health outcomes and should be investigated in the 
short term.  National coordination of record linkages is desirable as currently there is some 
duplication of effort across jurisdictions.   
Conclusion 
Public health surveillance on diabetes provides an opportunity to examine which population groups 
are most at risk, thus providing a basis for the development of timely and appropriate preventive 
and treatment programs.  This information is also used to provide guidance in allocating resources 
to satisfy current and future needs for diabetes-related health services (25).   
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Attachment A 
National Health Survey 
Questions on diabetes 
417. HAVE YOU EVER BEEN TOLD BY A DOCTOR OR A NURSE THAT YOU 
HAVE -  
 DIABETES? ……………………………………………………………… 1 
 HIGH SUGAR LEVELS IN YOUR BLOOD OR URINE? …………….. 2 
 Neither …………………………………………… Q. 435 3 
418. DO YOU CURRENTLY HAVE (DIABETES/HIGH SUGAR LEVELS)? 
 Yes …………………………………………………………………. 1 
 No ………………………………………………………………….. 2 
 Don’t know ………………………………………………………… 3 
419.  Sequence Guide 
. If ‘2’ in Q. 417 ………………………………………….. Q. 421 1 
. Otherwise ……………………………………………….. Q. 420 2 
420.  WHAT TYPE OF DIABETES WERE YOU TOLD YOU HAVE? 
 Insulin Dependent Diabetes Mellitus (Type 1) …….………………. 078 
 Non-Insulin Dependent Diabetes Mellitus (Type 2) …….……….… 079 
 Diabetes Mellitus Type Unknown ……………………….……….… 093 
 Other (Specify) …………………..……………………….……….…  
 ……………….…………………..……………………….……….… 990 
 Don’t know ………………………………………………………… 093 
421.  AT WHAT AGE WERE YOU FIRST TOLD THAT YOU HAVE 
(DIABETES/HIGH SUGAR LEVELS)? 
 Years  …….………………………...  
 Less than 1 year old …….…………………….…….… 98 
 Don’t know …………………………………………… 99 
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422.  HAVE YOU EVER BEEN GIVEN DIETARY ADVICE FOR THIS CONDITION? 
 Yes …………………………………………………………………. 1 
 No ………………………………………………….. Q. 425 2 
423.  HOW OLD WERE YOU WHEN YOU WERE FIRST GIVEN THIS ADVICE? 
 Years  …….………………………...  
 Less than 1 year old …….…………………….…….… 98 
 Don’t know …………………………………………… 99 
424.  ARE YOU CURRENTLY TRYING TO FOLLOW DIETARY ADVICE MOST OF 
THE TIME? 
 Yes …………………………………………………………………. 1 
 No ………………………………………………………………….. 2 
425.  (APART FROM DIETARY ADVICE) HAVE YOU EVER RECEIVED ANY 
(OTHER) TREATMENT FOR (DIABETES/HIGH SUGAR LEVELS)? 
 Yes …………………………………………………………………. 1 
 No ………………………………………………….. Q. 438 2 
426.  (APART FROM DIETARY ADVICE) HOW OLD WERE YOU WHEN YOU 
FIRST RECEIVED ANY (OTHER) TREATMENT? 
 Years  …….………………………...  
 Less than 1 year old …….…………………….…….… 98 
 Don’t know …………………………………………… 99 
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427.  (INCLUDING DIETARY ADVICE) WHAT TREATMENT OR ADVICE WERE 
YOU FIRST GIVEN WHEN YOUR CONDITION WAS FIRST DIAGNOSED? 
 Insulin ……………………………………………………a 1 
 Tablets ……………………………………………………b 2 
 Diet …………………………….…………………………c 3 
 Exercise …………..………………………………………d 4 
 Lose weight ………………………………………………e 5 
 Other ………………………………………………..……f 6 
428.  (APART FROM DIETARY ADVICE/EXERCISE/LOSING WEIGHT) ARE YOU 
CURRENTLY ON ANY TREATMENT FOR (DIABETES/HIGH SUGAR 
LEVELS)? 
 Yes …………………………………………………………………. 1 
 No ………………………………………………….. Q. 438 2 
429.  WHAT TREATMENT ARE YOU CURRENTLY HAVING? 
 Insulin ……………………………………………………a 1 
 Tablets ……………………………………………………b 2 
 Other ………………………………………………..……c 3 
430.  Sequence Guide 
. If code ‘1’ marked in Q. 429…………………………….. Q. 431 1 
. Otherwise ……………………………………………….. Q. 438 2 
431.  ARE YOU CURRENTLY HAVING INSULIN INJECTIONS DAILY? 
 Yes …………………………………………………………………. 1 
 No ………………………………………………….. Q. 438 2 
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432.  AT WHAT AGE DID YOU START HAVING DAILY INSULIN INJECTIONS? 
 Years  …….………………………...  
 Less than 1 year old …….…………………….…….… 98 
 Don’t know …………………………………………… 99 
433.  DO YOU EXPECT TO STILL BE HAVING DAILY INSULIN INJECTIONS TWO 
YEARS FROM NOW? 
 Yes …………………………………………………………………. 1 
 No ………………………………………………………………….. 2 
 Don’t know ………………………………………………………… 3 
434.  Q. 438 
435.  DO YOU SUSPECT YOU MAY CURRENLY HAVE -  
 DIABETES? ……………………………………………………………… 1 
 HIGH SUGAR LEVELS IN YOUR BLOOD OR URINE? …………….. 2 
 Neither …………………………………………… Q. 438 3 
436.  HAVE YOU EVER BEEN TESTED FOR DIABETES OR HIGH BLOOD SUGAR 
LEVELS? 
 Yes …………………………………………………………………. 1 
 No ………………………………………………….. Q. 438 2 
 Don’t know ..……………………………………….. Q. 438 3 
437.  HOW LONG AGO WAS YOUR LAST TEST? 
 Years …….………………………...  
 Less than 1 year ago …….…………………….…….… 98 
 Don’t know …………………………………………… 99 
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Attachment B 
Behavioural Risk Factor Surveillance System 
Optional Modules 
Module 1: Diabetes 
1.  How old were you when you were told you have diabetes? (202-203) 
 Code age in years [97 = 97 and older] __ __ 
 Don’t know/Not sure 9   8 
 Refused 9   9 
2.  Are you now taking insulin? (204) 
 a. Yes 1 
 b. No 2 
 Refused 9 
3. Are you now taking diabetes pills? (205) 
 a. Yes 1 
 b. No 2 
 Don’t know/Not sure 7 
 Refused 9 
4. About how often do you check your blood for glucose or sugar?  Include times when 
checked by a family member or friend, but do not include times when checked by a health 
professional. (206-208) 
 a. Times per day 1 __ __ 
 b. Times per week 2 __ __ 
 c. Times per month 3 __ __ 
 d. Times per year 4 __ __ 
 e. Never 8  8  8 
 Don’t know/Not sure 7  7  7 
 Refused 9  9  9 
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5.  About how often do you check your feet for any sores or irritations?  Include times when 
checked by a family member or friend, but do not include times when checked by a health 
professional. (209-211) 
 a. Times per day 1 __ __ 
 b. Times per week 2 __ __ 
 c. Times per month 3 __ __ 
 d. Times per year 4 __ __ 
 e. Never 8  8  8 
 f. Not feet 5  5  5 
 Don’t know/Not sure 7  7  7 
 Refused 9  9  9 
6. Have you ever had any sores or irritations on your feet that took more than four weeks to 
heal? (212) 
 a. Yes 1 
 b. No 2 
 Don’t know/Not sure 7 
 Refused 9 
7. About how many times in the past 12 months have you seen a doctor, nurse, or other health 
professional for your diabetes? (213-214) 
 a. Number of times __ __ 
 b. None 8  8 
 Don’t know/Not sure 7  7 
 Refused 9  9 
   
8.  A test for hemoglobin “A one C” measures the average level of blood sugar over the past 
three months.  About how many times in the past 12 months has a doctor, nurse, or other 
health professional checked you for hemoglobin “A one C”? (215-216) 
 a. Number of times [76 = 76 or more] __ __ 
 b. None 8  8 
 c. Never heard of hemoglobin “A one C” test 9  8 
 Don’t know/Not sure 7  7 
 Refused 9  9 
 
9.  About how many times in the past 12 months has a health profession
any sores or irritations? 
 a. Number of times 
 b. None 
 Don’t know/Not sure 
 Refused 
10.  When was the last time you had an eye exam in which the pupils dila
made you temporarily sensitive to bright light.   
 a. Within the past month (0 to 1 month ago) 
 b. Within the past year (1 to 12 months ago) 
 c. Within the past 2 years (1 to 2 years ago) 
 d. 2 or more years ago 
 e. Never 
 Don’t know/Not sure 
 Refused 
If “no feet” to Q5, go to Q1023
al checked your feet for 
(217-218) 
__ __ 
8  8 
7  7 
9  9 









   24
11.  Has a doctor ever told you that diabetes has affected your eyes or that you had retinopathy?
 (220) 
 a. Yes 1 
 b. No 2 
 Don’t know/Not sure 7 
 Refused 9 
12. Have you ever taken a course or class how to manage your diabetes yourself? (221) 
 a. Yes 1 
 b. No 2 
 Don’t know/Not sure 7 
 Refused 9 
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Attachment C 
 
National Health and Nutrition Examination Survey 
 
DIABETES - DIQ 
DIQ.010  The next questions are about specific medical conditions. 
 {Other than during pregnancy, {have you/has SP}/{Have you/Has SP}} ever been 
told by a doctor or health professional that {you have/{he/she/SP} has} diabetes or 
sugar diabetes? 
 
 CAPI INSTRUCTION: 
 IF SP AGE < 12, DISPLAY "HAVE YOU" FOR THE FIRST DISPLAY AND "SP 
HAS" FOR THE SECOND DISPLAY. 
 IF SP IS FEMALE AND AGE >= 20, DISPLAY "OTHER THAN DURING 
PREGNANCY, {HAVE YOU/HAS SP}". 
 
 YES ................................................. 1 
 NO .................................................... 2 (DIQ.050) 
 BORDERLINE ................................ 3 (DIQ.050) 
 REFUSED ........................................ 7 (DIQ.050) 
 DON'T KNOW ................................. 9 (DIQ.050) 
DIQ.040  How old {was SP/were you} when a doctor or other health professional first told 
{you/him/her} that {you/he/she} had diabetes or sugar diabetes? 
 CAPI INSTRUCTION: 
 IF SP AGE < 12, DISPLAY "YOU" FOR THE SECOND DISPLAY. 
 
 |___|___| 
 ENTER AGE IN YEARS 
 
 LESS THAN 1 YEAR ................. 666 
 REFUSED ................................... 777 
 DON'T KNOW ............................. 999 
DIQ.050  {Is SP/Are you} now taking insulin? 
 YES .................................................. 1 
 NO ................................................... 2 (BOX 0) 
 REFUSED ....................................... 7 (BOX 0) 
 DON'T KNOW ............................... 9 (BOX 0) 
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DIQ.060  For how long {have you/has SP} been taking insulin? 
 |___|___|___| 
 ENTER NUMBER (OF MONTHS OR YEARS) 
 
 LESS THAN 1 MONTH ............ 666 
 REFUSED ................................... 777 
 DON'T KNOW ........................... 999 
 
 ENTER UNIT 
 
 MONTHS ........................................ 1 
 YEARS ............................................ 2 
 REFUSED ….............................….... 7 
 DON'T KNOW ..…....…................... 9 
BOX 0 
CHECK ITEM DIQ.065: 
 
IF 'YES' (CODE 1) IN DIQ.010, CONTINUE. 
OTHERWISE, GO TO BOX 2. 
DIQ.070  {Is SP/Are you} now taking diabetic pills to lower {{his/her}/your} blood sugar? 
These are sometimes called oral agents or oral hypoglycemic agents. 
 YES .................................................. 1 
 NO ................................................... 2 
 REFUSED ...........................….......... 7 
 DON'T KNOW ................................ 9 
BOX 1 
CHECK ITEM DIQ.075: 
 
IF SP AGE >= 20, CONTINUE. 
OTHERWISE, GO TO END OF SECTION. 
DIQ.080  Has a doctor ever told {you/SP} that diabetes has affected {your/his/her} eyes or that 
{you/s/he} had retinopathy? 
 YES .................................................. 1 
 NO ........................................................ 2 
 REFUSED ........................................... 7 
 DON'T KNOW ….............................. 9 
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BOX 2 
CHECK ITEM DIQ.085: 
IF SP AGE >= 40, CONTINUE. 
OTHERWISE, GO TO END OF SECTION. 
DIQ.090  {Have you/Has SP} ever had an ulcer or sore on {your/his/her} leg or foot that took 
more than 4 weeks to heal? 
 YES .................................................. 1 
 NO ........................................................ 2 
 REFUSED ........................................... 7 
 DON'T KNOW ….............................. 9 
DIQ.100  During the past 3 months, {have you/has SP} had numbness or loss of feeling in 
{your/his/her} hands or feet, other than from {your/his/her} hands or feet falling 
asleep? 
 YES .................................................. 1 
 NO ................................................... 2 (DIQ.120) 
 REFUSED ........................................ 7 (DIQ.120) 
 DON'T KNOW ................................ 9 (DIQ.120) 
DIQ.110  Has the numbness or loss of feeling been in {your/SP's} hands, feet, or both? 
 HANDS ............................................ 1 
 FEET ................................................ 2 
 BOTH ............................................... 3 
 REFUSED ........................................ 7 
 DON'T KNOW ................................ 9 
DIQ.120  During the past 3 months, {have you/has SP} had a painful sensation or tingling in 
{your/his/her} hands or feet? Do not include normal foot aches from standing or 
walking for long periods. 
 YES .................................................. 1 
 NO ................................................... 2 (DIQ.140) 
 REFUSED ........................................ 7 (DIQ.140) 
 DON'T KNOW ................................ 9 (DIQ.140) 
DIQ.130  Has the painful sensation or tingling been in {your/his/her} hands, feet, or both? 
 HANDS ........................................... 1 
 FEET ................................................... 2 
 BOTH .................................................. 3 
 REFUSED ........................................... 7 
 DON'T KNOW .................................. 9 
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DIQ.140  {Do you/Does SP} ever get pain in either leg while {you are/s/he is} walking? 
 YES .................................................. 1 
 NO ........................................................ 2 (END OF SECTION) 
 REFUSED ........................................... 7 (END OF SECTION) 
 DON'T KNOW ................................... 9 (END OF SECTION) 
DIQ.150  Does this pain include pain in {your/SP's} calf or calves? 
 YES .................................................. 1 
 NO .................................................... 2 
 REFUSED ......................................... 7 
 DON'T KNOW ................................. 9 
